Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma (Q37214300)
Jump to navigation
Jump to search
scientific article published on 05 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma |
scientific article published on 05 September 2013 |
Statements
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma (English)
R Iacovelli
L Burattini
L Rossi
S Luca Burgio
G Muzzonigro
E Cortesi
5 September 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference